1. Cardiovascular safety of BCR-ABL1 tyrosine kinase inhibitors: imatinib and ponatinib decrease plasma cholesterol and atherosclerosis in APOE3*Leiden.CETP Mice. (August 2017) Authors: Pouwer, Marianne; Pieterman, Elsbet; Verschuren, Lars; Caspers, Martien; Kluft, Kees; Garcia, Ricardo; Lee, Frank; Aman, Jurjan; Jukema, Wouter; Princen, Hans Journal: Atherosclerosis Issue: Volume 263(2017) Page Start: e29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice. Issue 12 (29th October 2018) Authors: Morrison, Martine C.; Verschuren, Lars; Salic, Kanita; Verheij, Joanne; Menke, Aswin; Wielinga, Peter Y.; Iruarrizaga‐Lejarreta, Marta; Gole, Laurent; Yu, Wei‐Miao; Turner, Scott; Caspers, Martien P.M.; Martínez‐Arranz, Ibon; Pieterman, Elsbet; Stoop, Reinout; van Koppen, Arianne; van den Hoek, A... Journal: Hepatology communications Issue: Volume 2:Issue 12(2018) Page Start: 1513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis. (19th July 2022) Authors: Carracedo, Miguel; Pawelzik, Sven‐Christian; Artiach, Gonzalo; Pouwer, Marianne G.; Plunde, Oscar; Saliba‐Gustafsson, Peter; Ehrenborg, Ewa; Eriksson, Per; Pieterman, Elsbet; Stenke, Leif; Princen, Hans M. G.; Franco‐Cereceda, Anders; Bäck, Magnus Journal: British journal of pharmacology Issue: Volume 179:Number 19(2022) Page Start: 4709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗